A Small-Cap Biotech Call With Room LeftVera Therapeutics, Inc. Class ANASDAQ:VERADarkFlowSignalsChart reference: daily VERA, with the $35 strike as the working level. Setup thesis. This is a bullish call idea on VERA, a small-cap biotech, that opened in late August and is still carrying green. The read was fresh institutional buying leaning long on a name with catalyst potential and a chart that had not yet gotten ahead of itself. Small-cap biotech is higher-torque in both directions, so this is a name to watch closely rather than set and forget. Trade structure. - Vehicle: $35 calls, mid-September expiry. - Small-cap torque means faster moves and wider swings, so the risk is kept modest. - Exit discipline: hard stop at negative 50 percent of premium, otherwise ride to expiry. What is confirming. The calls sit near +31 percent and peaked around +46 percent. A steady climb without a blow-off, which leaves room if the name gets a catalyst. What would invalidate. A close back below the strike, or a biotech-wide risk-off move, would be the signal to step back. Small-caps can round-trip a gain quickly, so this one earns closer watching than the large-caps. Outcome (open, carrying). Current near +31 percent, peak near +46 percent. Still constructive, with the caveat that small-cap gains are the ones that need the tightest attention. How I find these. DarkFlow reads fresh institutional flow off the live tape with multiple confirming signals, then lets the read make the call. Full track record at darkflowsignals.com.